APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 29 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $62,000 | +14.8% | 41,000 | -6.8% | 0.00% | 0.0% |
| Q3 2021 | $54,000 | -73.1% | 44,000 | -59.6% | 0.00% | -66.7% |
| Q2 2021 | $201,000 | +68.9% | 109,000 | +28.2% | 0.00% | +50.0% |
| Q1 2021 | $119,000 | -13.8% | 85,000 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $138,000 | – | 82,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 15,000,000 | $35,954,355 | 1.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $28,207,024 | 0.34% |
| LINDEN ADVISORS LP | 10,000,000 | $23,952,985 | 0.25% |
| Verition Fund Management LLC | 4,796 | $11,487,633 | 0.15% |
| LORD, ABBETT & CO. LLC | 11,712,000 | $28,044 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,267,000 | $3,044,070 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 14,242,000 | $34,113 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $717,076 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $11,995,383 | 0.01% |
| Citadel Advisors | 11,500,000 | $27,556,934 | 0.01% |